Suchergebnisse - "Cattaneo, Daniele"

PubPharm (198)

1

Incidence of blast phase in myelofibrosis patients according to anemia severity at ruxolitinib start and during therapy

enthalten in: Cancer | 2024

von Palandri, F. | Palumbo, G. | Benevolo, G. | +34

2

Newly identified roles for PIEZO1 mechanosensor in controlling normal megakaryocyte development and in primary myelofibrosis

enthalten in: American journal of hematology | 2024

von Abbonante, V. | Karkempetzaki, A. | Leon, C. | +13

3

The new Systematic Coronary Risk Evaluation (SCORE2 and SCORE2-OP) estimates the risk of arterial occlusive events in chronic myeloid leukemia patients treated with nilotinib or ponatinib

enthalten in: Annals of hematology | 2024

von Mulas, O. | Abruzzese, E. | Luciano, L. | +26

4

The molecular landscape of myeloproliferative neoplasms associated with splanchnic vein thrombosis : Current perspective

enthalten in: Leukemia research | 2024

von Pescia, C. | Lopez, G. | Cattaneo, D. | +3

5

Ropeginterferon phase 2 randomized study in low-risk polycythemia vera : 5-year drug survival and efficacy outcomes

enthalten in: Annals of hematology | 2024

von Barbui, T. | Carobbio, A. | De Stefano, V. | +38

6

Newly identified roles for PIEZO1 mechanosensor in controlling normal megakaryocyte development and in primary myelofibrosis

enthalten in: American Journal of Hematology | 2024

von Abbonante, V. | Karkempetzaki, A. | Leon, C. | +13

7

Incidence of blast phase in myelofibrosis patients according to anemia severity at ruxolitinib start and during therapy

enthalten in: Cancer | 2024

von Palandri, F. | Palumbo, G. | Benevolo, G. | +34

8

Ropeginterferon phase 2 randomized study in low-risk polycythemia vera: 5-year drug survival and efficacy outcomes

enthalten in: Annals of hematology | 2023

von Barbui, T. | Carobbio, A. | De Stefano, V. | +38

9

Cardiovascular Adverse Events of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia : Clinical Relevance, Impact on Outcome, Preventive Measures and Treatment Strategies

enthalten in: Current treatment options in oncology | 2023

von Iurlo, A. | Cattaneo, D. | Bucelli, C. | +2

10

Cardiovascular Adverse Events of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: Clinical Relevance, Impact on Outcome, Preventive Measures and Treatment Strategies

enthalten in: Current treatment options in oncology | 2023

von Iurlo, A. | Cattaneo, D. | Bucelli, C. | +2

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[20]